Lysophosphatidic acid and invasion

Cancer Treat Res. 2009:149:269-96. doi: 10.1007/978-0-387-98094-2_13.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Cell Hypoxia
  • Cyclooxygenase 2
  • Diterpenes / pharmacology
  • Female
  • Humans
  • Interleukins / physiology
  • Intracellular Signaling Peptides and Proteins / physiology
  • Lysophospholipids / antagonists & inhibitors
  • Lysophospholipids / physiology*
  • Membrane Lipids / metabolism
  • Mice
  • Multienzyme Complexes / physiology
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Proteins / physiology
  • Neovascularization, Pathologic / physiopathology
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology
  • Peptide Hydrolases / physiology
  • Phosphodiesterase I / physiology
  • Phospholipases A / physiology
  • Phosphoric Diester Hydrolases
  • Pyrophosphatases / physiology
  • Receptors, Lysophosphatidic Acid / physiology
  • Signal Transduction / physiology*
  • Sphingosine / analogs & derivatives
  • Sphingosine / physiology
  • Vascular Endothelial Growth Factor A / physiology

Substances

  • Antineoplastic Agents
  • Diterpenes
  • Interleukins
  • Intracellular Signaling Peptides and Proteins
  • Lysophospholipids
  • Membrane Lipids
  • Multienzyme Complexes
  • Neoplasm Proteins
  • Receptors, Lysophosphatidic Acid
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • sphingosine 1-phosphate
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Phospholipases A
  • Phosphoric Diester Hydrolases
  • Phosphodiesterase I
  • alkylglycerophosphoethanolamine phosphodiesterase
  • Peptide Hydrolases
  • Pyrophosphatases
  • Sphingosine
  • lysophosphatidic acid
  • geranylgeranylacetone